Skip to main content

Versant Vantage I, L.P.'s Form 4 filing

Repare Therapeutics Inc.RPTX · filed Jun 7, 2022

Accession no.
0000899243-22-021350
Filed
Jun 7, 2022, 4:37 PM ET
Trade date
Jun 3-6, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 15 non-derivative transactions. Open-market sales total $9.19M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Versant Vantage I, L.P.CIK 000176525310% Owner
Versant Vantage I GP, L.P.CIK 000177765110% Owner
Versant Vantage I GP-GP, LLCCIK 000177765310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 3, 2022Common SharesSSaleDisposed−250,000$12.25F1−$3,062,9252,344,451IndirectDuplicate filing
Jun 3, 2022Common SharesSSaleDisposed−438,795$12.25F1−$5,375,984.71,464,875IndirectDuplicate filing
Jun 3, 2022Common SharesSSaleDisposed−13,199$12.25F1−$161,710.1944,065IndirectDuplicate filing
Jun 3, 2022Common SharesSSaleDisposed−14,611$12.25F1−$179,009.5948,776IndirectDuplicate filing
Jun 3, 2022Common SharesSSaleDisposed−33,395$12.25F1−$409,145.52111,484IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−614,315$0.00$0850,560IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherAcquired+132,692$0.00$0132,692IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−18,478$0.00$025,587IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherAcquired+3,992$0.00$0136,684IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−20,454$0.00$028,322IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherAcquired+4,419$0.00$0141,103IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−141,103$0.00$00IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−46,753$0.00$064,731IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherAcquired+10,099$0.00$010,099IndirectDuplicate filing
Jun 6, 2022Common SharesJOtherDisposed−10,099$0.00$00IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Referenced by the price of 5 transactions in Table I.

Remarks

2 of 2: Since there are 13 joint filers and EDGAR will not allow for entry of more than 10 joint filers, this Form 4 is being filed in conjunction with a Form 4 for Versant Ventures V, LLC, Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P., Versant Venture Capital V (Canada) LP, Versant Venture Capital V, L.P., Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc., Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P. and Versant Ventures VI GP-GP, LLC.

Read the full filing on SEC EDGAR (opens in a new tab)